Second Sight Medical (EYES) IPO Opens Sharply Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/9/2026
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Brent climbs $1 on uncertainty over end to Iran war
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Atlassian results seen as 'game changer' for AI kills software worries
- Microsoft only US hyperscaler with positive free cash flow as AI capex bites
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Second Sight Medical (EYES) Sees Profit Taking after 162% Post-IPO Surge
November 21, 2014 10:25 AM ESTThis week's hot IPO for Second Sight Medical (NASDAQ: EYES) is giving some back today. After gaining 162% in it fist two days of trading, shares are down 9.5% to $21.35 today. The IPO priced at $9.
Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients
... MoreSecond Sight Medical (EYES) Momentum Continues Following Robust IPO
November 20, 2014 8:44 AM ESTSecond Sight Medical (NASDAQ: EYES) is showing early gains Thursday following the company's strong debut on yesterday's session.
Wednesday, Second Sight opened for trading at $17 after pricing 3.5 million common shares at $9 apiece. Overall, the stock close 122 percent higher to $19.97.
Ahead of the bell, Second Sight is up an additional 15 percent.
... MoreSecond Sight Medical (EYES) Picks Up Chatter Ahead of CNBC Coverage
November 19, 2014 12:50 PM ESTWhile off the highs, traders are getting chatty about today's IPO for Second Sight Medical Products (NASDAQ: EYES) as it is expected to be highlighted on CNBC in a little while. Shares are up 105% at last check to $18.50 after pricing at $9.
... MoreSecond Sight Medical Products (EYES) Prices 3.5M Common IPO at $9/Share
November 19, 2014 7:56 AM ESTSecond Sight Medical Products, Inc. (Nasdaq: EYES) announced the pricing of its initial public offering of 3,500,000 shares of common stock, at a price of $9.00 per share. Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients. Its current product, the Argus® II System, which treats outer retinal degenerations such as retinitis... More
